Insurance Policy in a Clinical Trial as an Element of Safety and Regulatory Compliance
An insurance policy in a clinical trial is not merely a formal regulatory requirement, but one of the key components of an effective risk management system. Its primary purpose is to protect study participants in the event of harm related to their participation. In practice, however, it also plays a crucial role in safeguarding the sponsor, CRO, and investigative sites.
The scope of the policy should be strictly aligned with the nature of the study, the patient population, and the type of intervention. Typically, it covers civil liability for damage to the health or life of participants arising from the conduct of the clinical trial. It is essential that the scope of coverage is clear and consistent with the study protocol. Ambiguous wording or an overly narrow definition of covered events may lead to significant challenges if claims are filed.
A common issue is treating the insurance policy as a “technical” document, reviewed only at the stage of application submission or contract execution with sites. In reality, deficiencies in coverage may result in delays in study start-up, additional questions from ethics committees or competent authorities, and in extreme cases, the need to renegotiate insurance terms during the project.
It is equally important to clearly define who is covered by the policy — participants, investigators, site staff, or operational partners. Any inconsistency between the policy, contractual agreements, and regulatory documentation increases the risk of disputes and may undermine sites’ trust in the organization of the study.
From a business perspective, a well-designed insurance policy contributes to overall project stability. It mitigates financial risk, enhances safety for all parties involved, and strengthens the credibility of the sponsor and CRO in the eyes of investigative sites and regulatory authorities. Mature organizations view insurance not as a cost, but as a strategic element of study preparation which, like the protocol or monitoring plan, should be carefully designed and reviewed at an early stage.
If you want to ensure that the insurance policy in your clinical trial truly protects your project and does not become a source of delays or risk, contact us — we will help you select and verify solutions tailored to the specific characteristics of your study.
